metformin vs glp 1 Full article: Will delayed release provide better management of diabetes type 2? GLP-1 RA initiation versus metformin

New insights into pancreatic cancer-induced paraneoplastic diabetes

A reduced risk of major adverse cardiovascular events (MACE) was reported in CVOTs for T2DM for dulaglutide [AWARD-7 (NCT01621178)] [53], liraglutide [LEADER (NCT01179048)] [54, 55], semaglutide [SUSTAIN-6 (NCT01720446)] [55], albiglutide [Harmony Outcomes (NCT02465515)] [56] and efpeglenatide [AMPLITUDE-O (NCT03496298)] [57]

The affluent self-pay customer, growing awareness of chronic diseases, and the demand for once-daily injectable therapies all contribute to market growth

Yet the researchers note that despite the rapid increase, overall adoption remained limited in 2022, with only about one in 250 U.S

You may feel the pain from your abdomen to your back changes in vision

GLP-1s have become a popular topic because of their important role in appetite regulation, blood sugar balance, and overall metabolic health